Skip to main content
SpringerLink
Log in

Epidemiologie des Hautkrebses

  • Chapter
Dermatologische Onkologie

Zusammenfassung

Die Epidemiologie des Hautkrebses ist in den letzten Dekaden eingehend untersucht worden. Ausschlaggebend dafür war die starke Zunahme der Inzidenz sowohl der epithelialen Hautkrebse als auch des malignen Melanoms. Für das maligne Melanom der Haut war mit der Zunahme der Inzidenz gleichzeitig eine Zunahme der Mortalität verbunden. Mit dieser Entwicklung traten das maligne Melanom der Haut und auch die epithelialen Hautkrebse aus dem Kreis der seltenen Entitäten in den Bereich derjenigen Neoplasien ein, die eine wichtige medizinische Bedeutung besitzen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abel EA (1989) Cutaneous manifestations of immunosuppression in organ transplant recipients. J Am Acad Dermatol 21: 167–179

    PubMed  CAS  Google Scholar 

  2. Albert VA, Koh HK, Geller AC, Miller DR, Prout MN, Lew RA (1990) Years of potential life lost: another indicator of the impact of cutaneous malignant melanoma on society. J Am Acad Dermatol 23: 308–310

    PubMed  CAS  Google Scholar 

  3. Angst E, Bisig B, Tschopp A, Sigg C, Schuler G, Gutzwiller F, Schnyder UW (1989) Die Melanommortalität in der Schweiz 1970–1986. Schweiz Med Wochenschr 119: 1591–1598

    PubMed  CAS  Google Scholar 

  4. Anonymus (1992) Death rates of malignant melanoma among white men-United States, 1973–1988. MMWR 41: 20–22, 27

    Google Scholar 

  5. Anonymus (1995) Deaths from melanoma-United States, 1973–1992. MMWR 44: 337, 343–347

    Google Scholar 

  6. Armstrong BK (1988) Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun? J Dermatol Surg Oncol 14: 835–849

    PubMed  CAS  Google Scholar 

  7. Armstrong BK, de Klerk NH, Holman CD (1986) Etiology of common acquired melanocytic nevi: constitutional variables, sun exposure, and diet. J Natl Cancer Inst 77: 329–335

    PubMed  CAS  Google Scholar 

  8. Armstrong BK, Kricker A (1993) How much melanoma is caused by sun exposure? Melanoma Res 3: 395–401

    PubMed  CAS  Google Scholar 

  9. Armstrong BK, Kricker A (1994) Cutaneous melanoma. Cancer Surv 19–20: 219–240

    Google Scholar 

  10. Austin PF, Cruse CW, Lyman G, Schroer K, Glass F, Reinigen DS (1994) Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol 1: 487–494

    PubMed  CAS  Google Scholar 

  11. Autier P, Dore JF, Lejeune F et al. (1994) Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: an EORTC multicenter case-control study in Belgium, France and Germany. EORTC Melanoma Cooperative Group. Int J Cancer 58: 809–813

    PubMed  CAS  Google Scholar 

  12. Autier P, Dore JF, Lejeune F et al. (1994) Recreational exposure to sunlight and lack of information as risk factors for cutaneous malignant melanoma. Results of an European Organization for Research and Treatment of Cancer (EORTC) case-control study in Belgium, France and Germany. The EORTC Malignant Melanoma Cooperative Group. Melanoma Res 4: 79–85

    PubMed  CAS  Google Scholar 

  13. Autier P, Dore JF, Schifflers E et al. (1995) Melanoma and use of sunscreens: an Eortc case-control study in Germany, Belgium and France. The EORTC Melanoma Cooperative Group. Int J Cancer 61: 749–755

    PubMed  CAS  Google Scholar 

  14. Autier P, Joarlette M, Lejeune F, Lienard D, Andre J, Achten G (1991) Cutaneous malignant melanoma and exposure to sunlamps and sunbeds: a descriptive study in Belgium. Melanoma Res 1: 69–74

    PubMed  CAS  Google Scholar 

  15. Balch CM, Soong SJ, Milton GW et al. (1983) Changing trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, Australia. Cancer 52: 1748–1753

    PubMed  CAS  Google Scholar 

  16. Battistutta D, Palmer J, Walters M, Walker G, Nancarrow D, Hayward N (1994) Incidence of familial melanoma and MLM2 gene. Lancet 344: 1607–1608

    PubMed  CAS  Google Scholar 

  17. Bavinck JN, de Boer A, Vermeer BJ et al. (1993) Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 129: 242–249

    PubMed  CAS  Google Scholar 

  18. Bavinck JN, Gissmann L, Claas FH et al. (1993) Relation between skin cancer, humoral responses to human papillomaviruses, and HLA class II molecules in renal transplant recipients. J Immunol 151: 1579–1586

    PubMed  CAS  Google Scholar 

  19. Boyle J, MacKie RM, Briggs JD, Junor BJ, Aitchison TC (1984) Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet 1: 702–705

    PubMed  CAS  Google Scholar 

  20. Bulliard JL, Raymond L, Levi F, Schuler G, Enderlin F, Pellaux S, Torhorst J (1992) Prevention of cutaneous melanoma: an epidemiological evaluation of the Swiss campaign. Rev Epidemiol Sante Publique 40: 431–438

    PubMed  CAS  Google Scholar 

  21. Burton RC, Armstrong BK (1995) Current melanoma epidemic: a nonmetastasizing form of melanoma? World J Surg 19: 330–333

    PubMed  CAS  Google Scholar 

  22. Burton RC, Coates MS, Hersey P et al. (1993) An analysis of a melanoma epidemic. Int J Cancer 55: 765–770

    PubMed  CAS  Google Scholar 

  23. Büttner P, Garbe C, Bertz J et al. (1995) Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark’s level for prognostic classification. Cancer 75: 2499–2506

    PubMed  Google Scholar 

  24. Carey WP Jr, Thompson CJ, Synnestvedt M, Guerry D 4th, Halpern A, Schultz D, Elder DE (1994) Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer 74: 3118–3125

    PubMed  Google Scholar 

  25. Carli P, Borgognoni L, Biggeri A, Carli S, Reali UM, Giannotti B (1994) Incidence of cutaneous melanoma in the centre of Italy: anatomic site distribution, histologic types and thickness of tumour invasion in a registry based study. Melanoma Res 4: 385–390

    PubMed  CAS  Google Scholar 

  26. Carmichael VE, Wilson KS (1992) Primary cutaneous malignant melanoma: experience of the British Columbia Cancer Agency from 1972 to 1981. Can J Surg 35: 589–597

    PubMed  CAS  Google Scholar 

  27. Cavalieri R, Macchini V, Mostaccioli S et al. (1993) Time trends in features of cutaneous melanoma at diagnosis: central-south Italy, 1962–1991. Ann 1st Super Sanita 29: 469–472

    CAS  Google Scholar 

  28. Christie D, Robinson K, Gordon I, Bisby J (1991) A prospective study in the Australian petroleum industry. II. Incidence of cancer. Br J Ind Med 48: 511–514

    PubMed  CAS  Google Scholar 

  29. Collins RJ (1984) Melanoma in the Chinese of Hong Kong. Emphasis on volar and subungual sites. Cancer 54: 1482–1488

    PubMed  CAS  Google Scholar 

  30. De Guire L, Theriault G, Iturra H, Provencher S, Cyr D, Case BW (1988) Increased incidence of malignant melanoma of the skin in workers in a telecommunications industry. Br J Ind Med 45: 824–828

    PubMed  Google Scholar 

  31. de Rooij MJ, Rampen FH, Schouten LJ, Neumann HA (1995) Skin cancer screening focusing on melanoma yields more selective attendance. Arch Dermatol 131: 422–425

    PubMed  Google Scholar 

  32. Elder DE (1995) Skin cancer. Melanoma and other specific nonmelanoma skin cancers. Cancer 75: 245–256

    PubMed  CAS  Google Scholar 

  33. Elwood JM, Gallagher RP (1983) Site distribution of malignant melanoma. Can Med Assoc J 128: 1400–1404

    PubMed  CAS  Google Scholar 

  34. Elwood JM, Whitehead SM, Davison J, Stewart M, Galt M (1990) Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburn. Int J Epidemiol 19: 801–810

    PubMed  CAS  Google Scholar 

  35. English DR, Heenan PJ, Holman CD et al. (1986) Melanoma in Western Australia 1975–76 to 1980–81: trends in demographic and pathological characteristics. Int J Cancer 37: 209–215

    PubMed  CAS  Google Scholar 

  36. Fritz K, Ziegler H (1983) Beitrag des Saarländischen Krebsregisters zur Epidemiologie der Hauttumoren. Z Hautkr 58: 901–915

    PubMed  CAS  Google Scholar 

  37. Gafa L, Filippazzo MG, Tumino R, Dardanoni G, Lanzarone F, Dardanoni L (1991) Risk factors of nonmelanoma skin cancer in Ragusa, Sicily: a case-control study. Cancer Causes Control 2: 395–399

    PubMed  CAS  Google Scholar 

  38. Gallagher RP, Elwood JM, Threlfall WJ, Band PR, Spinelli JJ (1986) Occupation and risk of cutaneous melanoma. Am J Ind Med 9: 289–294

    PubMed  CAS  Google Scholar 

  39. Gallagher RP, Elwood JM, Threlfall WJ, Spinelli JJ, Fincham S, Hill GB (1987) Socioeconomic status, sunlight exposure, and risk of malignant melanoma: the Western Canada Melanoma Study. J Natl Cancer Inst 79: 647–652

    PubMed  CAS  Google Scholar 

  40. Gallagher RP, Elwood JM, Yang CP (1989) Is chronic sunlight exposure important in accounting for increases in melanoma incidence? Int J Cancer 44: 813–815

    PubMed  CAS  Google Scholar 

  41. Gallagher RP, Hill GB, Bajdik CD, Coldman AJ, Fincham S, McLean DI, Threlfall WJ (1995) Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma. Arch Dermatol 131: 164–169

    PubMed  CAS  Google Scholar 

  42. Gallagher RP, Hill GB, Bajdik CD, Fincham S, Coldman AJ, McLean DI, Threlfall WJ (1995) Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 131: 157–163

    PubMed  CAS  Google Scholar 

  43. Gallagher RP, McLean DI, Yang CP, Coldman AJ, Silver HK, Spinelli J J, Beagrie M (1990) Anatomic distribution of acquired melanocytic nevi in white children. A comparison with melanoma: the Vancouver Mole Study. Arch Dermatol 126: 466–471

    PubMed  CAS  Google Scholar 

  44. Gallagher RP, McLean DI, Yang CP, Coldman AJ, Silver HK, Spinelli JJ, Beagrie M (1990) Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study. Arch Dermatol 126: 770–776

    PubMed  CAS  Google Scholar 

  45. Garbe C (1992) Sonne und malignes Melanom. Hautarzt 43: 251–257

    PubMed  CAS  Google Scholar 

  46. Garbe C, Bertz J, Orfanos CE (1986) Malignes Melanom: Zunahme von Inzidenz und Mortalität in der Bundesrepublik Deutschland. Z Hautkr 61: 1751–1764

    PubMed  CAS  Google Scholar 

  47. Garbe C, Büttner P, Bertz J et al. (1995) Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer 75: 2492–2498

    PubMed  CAS  Google Scholar 

  48. Garbe C, Büttner P, Bertz J et al. (1995) Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer 75: 2484–2491

    PubMed  CAS  Google Scholar 

  49. Garbe C, Büttner P, Ellwanger U et al. (1995) Das Zentralregister Malignes Melanom der Deutschen Dermatologischen Gesellschaft in den Jahren 1983–1993. Epidemiologische Entwicklungen und aktuelle therapeutische Versorgung des malignen Melanoms der Haut. Hautarzt 46: 683–692

    PubMed  CAS  Google Scholar 

  50. Garbe C, Büttner P, Weiss J et al. (1994) Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 102: 700–705

    PubMed  CAS  Google Scholar 

  51. Garbe C, Büttner P, Weiss J et al. (1994) Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 102: 695–699

    PubMed  CAS  Google Scholar 

  52. Garbe C, Krüger S, Stadler R, Guggenmoos Holzmann I, Orfanos CE (1989) Markers and relative risk in a German population for developing malignant melanoma. Int J Dermatol 28: 517–523

    PubMed  CAS  Google Scholar 

  53. Garbe C, Orfanos CE (1989) Epidemiologie des malignen Melanoms in der Bundesrepublik Deutschland im internationalen Vergleich. Onkologie 12: 253–262

    PubMed  CAS  Google Scholar 

  54. Garbe C, Orfanos CE (1992) Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society. Pigment Cell Res [Suppl] 2: 285–294

    PubMed  Google Scholar 

  55. Garbe C, Thiess S, Nürnberger F, Ehlers G, Albrecht G, Lindlar F, Bertz J (1991) Incidence and mortality of malignant melanoma in Berlin (West) from 1980 to 1986. Acta Derm Venereol 71: 506–511

    PubMed  CAS  Google Scholar 

  56. Garbe C, Weiss J, Krüger S et al. (1993) The German melanoma registry and environmental risk factors implied. Recent Results Cancer Res 128

    Google Scholar 

  57. Garbe C, Wiebelt H, Orfanos CE (1989) Change of epidemiological characteristics of malignant melanoma during the years 1962–1972 and 1983–1986 in the Federal Republic of Germany. Dermatologica 178: 131–135

    PubMed  CAS  Google Scholar 

  58. Garland CF, Garland FC, Gorham ED (1992) Could sunscreens increase melanoma risk? Am J Public Health 82: 614–615

    PubMed  CAS  Google Scholar 

  59. Garland CF, Garland FC, Gorham ED (1993) Rising trends in melanoma. An hypothesis concerning sunscreen effectiveness. Ann Epidemiol 3: 103–110

    PubMed  CAS  Google Scholar 

  60. Glass AG, Hoover RN (1989) The emerging epidemic of melanoma and squamous cell skin cancer. JAMA 262: 2097–2100

    PubMed  CAS  Google Scholar 

  61. Goldstein AM, Tucker MA (1995) Genetic epidemiology of familial melanoma. Dermatol Clin 13: 605–612

    PubMed  CAS  Google Scholar 

  62. Gong G, Whittemore AS, West D, Moore DH, 2d (1992) Cutaneous melanoma at Lawrence Livermore National Laboratory: comparison with rates in two San Francisco bay area counties. Cancer Causes Control 3: 191–197

    PubMed  CAS  Google Scholar 

  63. Goodman KJ, Bible ML, London S, Mack TM (1995) Proportional melanoma incidence and occupation among white males in Los Angeles County (California, United States). Cancer Causes Control 6: 451–459

    PubMed  CAS  Google Scholar 

  64. Goss BD, Forman D, Ansell PE, Bennett V, Swerdlow AJ, Bürge S, Ryan TJ (1990) The prevalence and characteristics of congenital pigmented lesions in newborn babies in Oxford. Paediatr Perinat Epidemiol 4: 448–457

    PubMed  CAS  Google Scholar 

  65. Graham Brown RA, Osborne JE, London SP, Fletcher A, Shaw D, Williams B, Bowry V (1990) The initial effects on workload and outcome of a public education campaign on early diagnosis and treatment of malignant melanoma in Leicestershire. Br J Dermatol 122: 53–59

    PubMed  CAS  Google Scholar 

  66. Green A (1992) A theory of site distribution of melanomas: Queensland, Australia. Cancer Causes Control 3: 513–516

    PubMed  CAS  Google Scholar 

  67. Green A, MacLennan R, Youl P, Martin N (1993) Site distribution of cutaneous melanoma in Queensland. Int J Cancer 53: 232–236

    PubMed  CAS  Google Scholar 

  68. Greene MH, Clark WH Jr, Tucker MA, Kraemer KH, Elder DE, Fräser MC (1985) High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med 102: 458–465

    PubMed  CAS  Google Scholar 

  69. Grob JJ, Gouvernet J, Aymar D et al. (1990) Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 66: 387–395

    PubMed  CAS  Google Scholar 

  70. Gutman M, Cnaan A, Inbar M, Shafir R, Chaitchik S, Rozin RR, Klausner JM (1991) Are malignant melanoma patients at higher risk for a second cancer? Cancer 68: 660–665

    PubMed  CAS  Google Scholar 

  71. Gutman M, Inbar M, Klausner JM, Chaitchik S (1993) Malignant melanoma in different ethnic groups in Israel. Incidence and biologic behavior. Cancer 71: 2746–2750

    PubMed  CAS  Google Scholar 

  72. Healy E, Collins P, Barnes L (1995) Nonmelanoma skin cancer in an Irish population: an appraisal of risk factors. Ir Med J 88: 58–59

    PubMed  CAS  Google Scholar 

  73. Heenan PJ (1985) Cutaneous malignant melanoma in western Australia. Pathology 17: 321–327

    PubMed  CAS  Google Scholar 

  74. Heenan PJ, English DR, Holman CD, Armstrong BK (1991) Survival among patients with clinical stage I cutaneous malignant melanoma diagnosed in Western Australia in 1975/1976 and 1980/1981. Cancer 68: 2079–2087

    PubMed  CAS  Google Scholar 

  75. Helmrich SP, Rosenberg L, Kaufman DW, Miller DR, Schottenfeld D, Stolley PD, Shapiro S (1984) Lack of an elevated risk of malignant melanoma in relation to oral contraceptive use. J Natl Cancer Inst 72: 617–620

    PubMed  CAS  Google Scholar 

  76. Herd RM, Cooper EJ, Hunter JA, Mclaren K, Chetty U, Watson AC, Gollock J (1995) Cutaneous malignant melanoma. Publicity, screening clinics and survival-the Edinburgh experience 1982–90. Br J Dermatol 132: 563–570

    PubMed  CAS  Google Scholar 

  77. Hersey P, Sillar RW, Howe CG et al. (1991) Factors related to the presentation of patients with thick primary melanomas. Med J Aust 154: 583–587

    PubMed  CAS  Google Scholar 

  78. Herzfeld PM, Fitzgerald EF, Hwang SA, Stark A (1993) A case-control study of malignant melanoma of the trunk among white males in upstate New York. Cancer Detect Prev 17: 601–608

    PubMed  CAS  Google Scholar 

  79. Hiatt RA, Krieger N, Sagebiel RW, Clark WH Jr, Mihm MC Jr (1993) Surveillance bias and the excess risk of malignant melanoma among employees of the Lawrence Liver more National Laboratory. Epidemiology 4: 43–47

    PubMed  CAS  Google Scholar 

  80. Hoffmann K, Dirschka T, Schatz H, Segerling M, Tiemann T, Hoffmann A, Altmeyer P (1993) A local education campaign on early diagnosis of malignant melanoma. Eur J Epidemiol 9: 591–598

    PubMed  CAS  Google Scholar 

  81. Holly EA (1986) Cutaneous melanoma and oral contraceptives: a review of case-control and cohort studies. Recent Results Cancer Res 102

    Google Scholar 

  82. Holly EA, Kelly JW, Shpall SN, Chiu SH (1987) Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 17: 459–468

    PubMed  CAS  Google Scholar 

  83. Iscovich J, Andreev H, Steinitz R (1995) Incidence of cutaneous malignant melanoma in Israel, 1960–1989. Public Health Rev 23: 1–23

    PubMed  CAS  Google Scholar 

  84. Jelfs PL, Giles G, Shugg D, Coates M, Durling G, Fitzgerald P, Ring I (1994) Cutaneous malignant melanoma in Australia, 1989. Med J Aust 161: 182–187

    PubMed  CAS  Google Scholar 

  85. Jones ME, Shugg D, Dwyer T, Young B, Bonett A (1992) Interstate differences in incidence and mortality from melanoma. A re-examination of the latitudinal gradient. Med J Aust 157: 373–378

    PubMed  CAS  Google Scholar 

  86. Jung HD (1988) Epidemiologie des malignen Melanoms in der Deutschen Demokratischen Republik. II. Mitteilung. Mortalität, Verhältnis Mortalität/Inzidenz, Üb erleb ensraten, Verlust an Arbeits jähren. Dermatol Monatsschr 174: 73–79.

    PubMed  CAS  Google Scholar 

  87. Kaldor J, Shugg D, Young B, Dwyer T, Wang YG (1993) Non-melanoma skin cancer: ten years of cancer-registry-based surveillance. Int J Cancer 53: 886–891

    PubMed  CAS  Google Scholar 

  88. Karakousis CP, Driscoll DL (1995) Prognostic parameters in localised melanoma: gender versus anatomical location. Eur J Cancer 31A: 320–324

    PubMed  CAS  Google Scholar 

  89. Kelly JW, Holly EA, Shpall SN, Ahn DK (1989) The distribution of melanocytic naevi in melanoma patients and control- subjects. Australas J Dermatol 30: 1–8

    PubMed  CAS  Google Scholar 

  90. Kelly JW, Rivers JK, MacLennan R, Harrison S, Lewis AE, Tate BJ (1994) Sunlight: a major factor associated with the development of melanocytic nevi in Australian 113. schoolchildren. J Am Acad Dermatol 30: 40–48

    PubMed  CAS  Google Scholar 

  91. Khlat M, Vail A, Parkin M, Green A (1992) Mortality from melanoma in migrants to Australia: variation by 114. age at arrival and duration of stay. Am J Epidemiol 135: 1103–1113

    PubMed  CAS  Google Scholar 

  92. Kirkpatrick CS, Lee JA, White E (1990) Melanoma risk 115. by age and socio-economic status. Int J Cancer 46: 1–4

    CAS  Google Scholar 

  93. Kirkpatrick CS, White E, Lee JA (1994) Case-control 116. study of malignant melanoma in Washington State. II. Diet, alcohol, and obesity. Am J Epidemiol 139: 869–880

    PubMed  CAS  Google Scholar 

  94. Ko CB, Walton S, Keczkes K, Bury HP, Nicholson C (1994) The emerging epidemic of skin cancer. Br J Dermatol 130: 269–272

    PubMed  CAS  Google Scholar 

  95. Koh HK, Caruso A, Gage I et al. (1990) Evaluation of melanoma/skin cancer screening in Massachusetts. Preliminary results. Cancer 65: 375–379.

    PubMed  CAS  Google Scholar 

  96. Koh HK, Geller AC (1995) Melanoma control in the United States: current status. Recent Results Cancer Res 139

    Google Scholar 

  97. Kopf AW, Kripke ML, Stern RS (1984) Sun and malignant 119. melanoma. J Am Acad Dermatol 11: 674–684

    PubMed  CAS  Google Scholar 

  98. Krüger S, Garbe C, Büttner P, Stadler R, Guggenmoos Holzmann I, Orfanos CE (1992) Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. 120. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol 26: 920–926.

    PubMed  Google Scholar 

  99. Kukita A, Ishihara K (1989) Clinical features and distribution of malignant melanoma and pigmented nevi on the soles of the feet in Japan. J Invest Dermatol 92: 210S-213S.

    PubMed  CAS  Google Scholar 

  100. Lee JA (1989) The relationship between malignant melanoma of skin and exposure to sunlight. Photochem Photobiol 50: 493–496.

    PubMed  CAS  Google Scholar 

  101. Lee JA, Scotto J (1993) Melanoma: linked temporal and latitude changes in the United States. Cancer Causes Control 4: 413–418

    PubMed  CAS  Google Scholar 

  102. Lee PY, Silverman MK, Rigel DS et al. (1992) Level of education and the risk of malignant melanoma. J Am 124. Acad Dermatol 26: 59–63

    CAS  Google Scholar 

  103. Leigh IM, Glover MT (1995) Skin cancer and warts in immunosuppressed renal transplant recipients. Recent Results Cancer Res 139 125.

    Google Scholar 

  104. Levi F, La Vecchia C, Te VC, Mezzanotte G (1988) Descriptive epidemiology of skin cancer in the Swiss Canton of Vaud. Int J Cancer 42: 811–816.

    CAS  Google Scholar 

  105. Lindegard B (1990) Mortality and fatality of cutaneous malignant melanoma in Sweden, 1982–1986. Biomed Pharmacother 44: 495–501

    PubMed  CAS  Google Scholar 

  106. Longstreth J (1988) Cutaneous malignant melanoma and 127. ultraviolet radiation: a review. Cancer Metastasis Rev 7: 321–333

    PubMed  CAS  Google Scholar 

  107. Lyon JL, Gardner K, Gress RE (1994) Cancer incidence 128. among Mormons and non-Mormons in Utah (United States) 1971–85. Cancer Causes Control 5: 149–156

    PubMed  CAS  Google Scholar 

  108. Mack TM, Floderus B (1991) Malignant melanoma risk 129. by nativity, place of residence at diagnosis, and age at migration. Cancer Causes Control 2: 401–411

    PubMed  CAS  Google Scholar 

  109. MacKie R, Hunter JA, Aitchison TC et al. (1992) Cutaneous malignant melanoma, Scotland, 1979–89. The Scottish Melanoma Group. Lancet 339: 971–975

    PubMed  CAS  Google Scholar 

  110. MacKie RM, Freudenberger T, Aitchison TC (1989) Personal risk-factor chart for cutaneous melanoma. Lancet 2: 487–490

    PubMed  CAS  Google Scholar 

  111. MacKie RM, Smyth JF, Soutar DS et al. (1985) Malignant melanoma in Scotland 1979–1983. Lancet 2: 859–863

    PubMed  CAS  Google Scholar 

  112. MacKie RM, Watt D, Doherty V, Aitchison T (1991) Malignant melanoma occurring in those aged under 30 in the west of Scotland 1979–1986: a study of incidence, clinical features, pathological features and survival. Br J Dermatol 124: 560–564

    PubMed  CAS  Google Scholar 

  113. MacLennan R, Green AC, McLeod GR, Martin NG (1992) Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 84: 1427–1432

    PubMed  CAS  Google Scholar 

  114. Magnus K (1991) The Nordic profile of skin cancer incidence. A comparative epidemiological study of the three main types of skin cancer. Int J Cancer 47: 12–19

    PubMed  CAS  Google Scholar 

  115. Marks R (1995) An overview of skin cancers. Incidence and causation. Cancer 75: 607–612

    PubMed  CAS  Google Scholar 

  116. Marks R, Jolley D, Dorevitch AP, Selwood TS (1989) The incidence of non-melanocytic skin cancers in an Australian population: results of a five-year prospective study. Med J Aust 150: 475–478

    PubMed  CAS  Google Scholar 

  117. McCredie M, Coates M, Grulich A (1994) Cancer incidence in migrants to New South Wales (Australia) from the Middle East, 1972–91. Cancer Causes Control 5: 414–421

    PubMed  CAS  Google Scholar 

  118. McLaughlin JK, Malker HS, Blot WJ, Ericsson JL, Gemne G, Fraumeni JF Jr (1988) Malignant melanoma in the printing industry. Am J Ind Med 13: 301–304

    PubMed  CAS  Google Scholar 

  119. Melia J, Cooper EJ, Frost T et al. (1995) Cancer Research Campaign health education programme to promote the early detection of cutaneous malignant melanoma. II. Characteristics and incidence of melanoma. Br J Dermatol 132: 414–421

    PubMed  CAS  Google Scholar 

  120. Nelemans PJ, Rampen FH, Groenendal H, Kiemeney LA, Ruiter DJ, Verbeek AL (1994) Swimming and the risk of cutaneous melanoma. Melanoma Res 4: 281–286

    PubMed  CAS  Google Scholar 

  121. Newell GR, Sider JG, Bergfelt L, Kripke ML (1988) Incidence of cutaneous melanoma in the United States by histology with special reference to the face. Cancer Res 48: 5036–5041

    PubMed  CAS  Google Scholar 

  122. Newton JN, Redburn J (1995) Incidence of melanoma in four English counties, 1989–92. Br Med J [Clin Res] 310: 502–503

    CAS  Google Scholar 

  123. Osterlind A, Hou Jensen K, Moller Jensen O (1988) Incidence of cutaneous malignant melanoma in Denmark 1978–1982. Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer. Br J Cancer 58: 385–391

    PubMed  CAS  Google Scholar 

  124. Palmer JR, Rosenberg L, Strom BL, Harlap S, Zauber AG, Warshauer ME, Shapiro S (1992) Oral contraceptive use and risk of cutaneous malignant melanoma. Cancer Causes Control 3: 547–554

    PubMed  CAS  Google Scholar 

  125. Paul E, Pausch A, Bodeker RH (1989) Speed of growth of melanoma: statistical analysis of the average ages of patient groups. Pigment Cell Res 2: 475–477

    PubMed  CAS  Google Scholar 

  126. Quaba AA, Wallace AF (1986) The incidence of malignant melanoma (0 to 15 years of age) arising in „large” congenital nevocellular nevi. Plast Reconstr Surg 78: 174–181

    PubMed  CAS  Google Scholar 

  127. Rauh M, Paul E, Illig L (1987) Incidence of malignant melanoma in Central Hesse, Germany. Anticancer Res 7: 447–448

    PubMed  CAS  Google Scholar 

  128. Rhodes AR (1995) Public education and cancer of the skin. What do people need to know about melanoma and nonmelanoma skin cancer? Cancer 75: 613–636

    PubMed  CAS  Google Scholar 

  129. Riou JP, Ariyan S, Brandow KR, Fielding LP (1995) The association between melanoma, lymphoma, and other primary neoplasms. Arch Surg 130: 1056–1061

    PubMed  CAS  Google Scholar 

  130. Roberts DL (1990) Malignant melanoma in West Glamorgan-increasing incidence and improving prognosis, 1986–88. Clin Exp Dermatol 15: 406–409.

    PubMed  CAS  Google Scholar 

  131. Roberts LK, Stanfield JW (1995) Suggestion that sunscreen use is a melanoma risk factor is based on inconclusive evidence. Melanoma Res 5: 377–379

    PubMed  CAS  Google Scholar 

  132. Roush GC, McKay L, Holford TR (1992) A reversal in the 147. long-term increase in deaths attributable to malignant melanoma. Cancer 69: 1714–1720

    PubMed  CAS  Google Scholar 

  133. Roush GC, Schymura MJ, Holford TR (1988) Patterns of 148. invasive melanoma in the Connecticut Tumor Registry. Is the long-term increase real? Cancer 61: 2586–2595

    PubMed  CAS  Google Scholar 

  134. Schaart FM, Garbe C, Orfanos CE (1993) Ozonabnahme und Hautkrebs: Versuch einer Risikoabschatzung. Hautarzt 44: 63–68

    PubMed  CAS  Google Scholar 

  135. Scotto J, Fears TR (1987) The association of solar ultraviolet and skin melanoma incidence among Caucasians in the United States. Cancer Invest 5: 275–283.

    PubMed  CAS  Google Scholar 

  136. Sober AJ (1987) Solar exposure in the etiology of cutaneous melanoma. Photodermatol 4: 23–31

    PubMed  CAS  Google Scholar 

  137. Stanganelli I, Raccagni AA, Baldassari L, Calista D, Serafini M, Bucchi L (1994) Analysis of Breslow tumor thickness distribution of skin melanoma in the Italian region of Romagna, 1986–1991. Tumori 80: 416–421

    PubMed  CAS  Google Scholar 

  138. Stern RS (1992) Risks of cancer associated with long term exposure to PUVA in humans: current status-1991. Blood Cells 18: 91–97

    CAS  Google Scholar 

  139. Stevens NG, Liff JM, Weiss NS (1990) Plantar melanoma: is the incidence of melanoma of the sole of the foot really higher in blacks than whites? Int J Cancer 45: 691–693

    PubMed  CAS  Google Scholar 

  140. Stidham KR, Johnson JL, Seigler HF (1994) Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of 154. gender in prognostic outcome. Arch Surg 129: 316–324

    PubMed  CAS  Google Scholar 

  141. Stierner U, Augustsson A, Rosdahl I, Suurkula M (1992) Regional distribution of common and dysplastic naevi in relation to melanoma site and sun exposure. A case control study. Melanoma Res 1: 367–375

    PubMed  CAS  Google Scholar 

  142. Storetvedt Heldaas S, Andersen AA, Langard S (1987) Incidence of cancer among vinyl chloride and polyvinyl 156. chloride workers: further evidence for an association with malignant melanoma. Br J Ind Med 44: 278–280

    PubMed  CAS  Google Scholar 

  143. Swerdlow AJ, English JS, Qiao Z (1995) The risk of melanoma in patients with congenital nevi: a cohort study. J Am Acad Dermatol 32: 595–599

    PubMed  CAS  Google Scholar 

  144. Thorn M, Bergstrom R, Adami HO, Ringborg U (1990) Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960–1984. Am J Epidemiol 132: 1066–1077

    PubMed  CAS  Google Scholar 

  145. Thorn M, Ponten F, Bergstrom R, Sparen P, Adami HO (1994) Trends in tumour characteristics and survival of malignant melanoma 1960–84: a population-based study in Sweden. Br J Cancer 70: 743–748

    PubMed  CAS  Google Scholar 

  146. Tucker MA, Boice JD Jr, Hoffman DA (1985) Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935–82. Natl Cancer Inst Monogr 68: 161–189

    PubMed  CAS  Google Scholar 

  147. Tucker MA, Misfeldt D, Coleman CN, Clark WH Jr, Rosenberg SA (1985) Cutaneous malignant melanoma after Hodgkin’s disease. Ann Intern Med 102: 37–41

    PubMed  CAS  Google Scholar 

  148. Vagero D, Ringback G, Kiviranta H (1986) Melanoma and other tumors of the skin among office, other indoor and outdoor workers in Sweden 1961–1979. Br J Cancer 53: 507–512

    PubMed  CAS  Google Scholar 

  149. Vagero D, Swerdlow AJ, Beral V (1990) Occupation and malignant melanoma: a study based on cancer registration data in England and Wales and in Sweden. Br J Ind Med 47: 317–324

    PubMed  CAS  Google Scholar 

  150. Vitasa BC, Taylor HR, Strickland PT et al. (1990) Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer 65: 2811–2817

    PubMed  CAS  Google Scholar 

  151. Walter SD, Marrett LD, From L, Hertzman C, Shannon HS, Roy P (1990) The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. Am J Epidemiol 131: 232–243

    PubMed  CAS  Google Scholar 

  152. Wassberg C, Thorn M, Yuen J, Ringborg U, Hakulinen T (1996) Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. Br J Cancer 73: 255–259

    PubMed  CAS  Google Scholar 

  153. Weiss J, Garbe C, Bertz J et al. (1990) Risikofaktoren für die Entwicklung maligner Melanome in der Bundesrepublik Deutschland. Ergebnisse einer multizentrischen Fall-Kontroll-Studie. Hautarzt 41: 309–313

    PubMed  CAS  Google Scholar 

  154. Westerdahl J, Olsson H, Ingvar C, Brandt L, Jonsson PE, Moller T (1992) Southern travelling habits with special reference to tumour site in Swedish melanoma patients. Anticancer Res 12: 1539–1542

    PubMed  CAS  Google Scholar 

  155. Westerdahl J, Olsson H, Masback A, Ingvar C, Jonsson N (1995) Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res 5: 59–65.

    PubMed  CAS  Google Scholar 

  156. Westerdahl J, Olsson H, Masback A et al. (1994) Use of sunbeds or sunlamps and malignant melanoma in southern Sweden. Am J Epidemiol 140: 691–699

    PubMed  CAS  Google Scholar 

  157. White E, Kirkpatrick CS, Lee JA (1994) Case-control study of malignant melanoma in Washington State. I. Constitutional factors and sun exposure. Am J Epidemiol 139: 857–868

    PubMed  CAS  Google Scholar 

  158. Zanetti R, Franceschi S, Rosso S, Colonna S, Bidoli E (1992) Cutaneous melanoma and sunburns in childhood in a southern European population. Eur J Cancer 28A: 1172–1176

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Claus Garbe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Sektion für Dermatologische Onkologie, Universitäts-Hautklinik Tübingen, Liebermeisterstraße 25, 72076, Tübingen, Germany

    Claus Garbe

  2. Dermatologische Klinik, Universitätsspital Zürich, Gloriastraße 31, CH-8091, Zürich, Switzerland

    Reinhard Dummer

  3. Zentrum der Dermatologie und Venerologie, Klinikum der Johann-Wolfgang von Goethe-Universität, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany

    Roland Kaufmann

  4. Universitäts-Hautklinik und Poliklinik Universität des Saarlandes, 66421, Homburg/Saar, Germany

    Wolfgang Tilgen

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Garbe, C. (1997). Epidemiologie des Hautkrebses. In: Garbe, C., Dummer, R., Kaufmann, R., Tilgen, W. (eds) Dermatologische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60622-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60622-9_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64480-1

  • Online ISBN: 978-3-642-60622-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation